Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (10): 1080-1086.doi: 10.3969/j.issn.1000-6621.2020.10.013
• Original Articles • Previous Articles Next Articles
MAO Yi, ZENG Yi-lan, WU Gui-hui, JIANG Zhi-hao, FAN Lin()
Received:
2020-08-11
Online:
2020-10-10
Published:
2020-10-15
Contact:
FAN Lin
E-mail:fanlinsj@163.com
MAO Yi, ZENG Yi-lan, WU Gui-hui, JIANG Zhi-hao, FAN Lin. Correlation analysis between clinical characteristics and flow cytometry cells subsets in peripheral blood of patients with pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1080-1086. doi: 10.3969/j.issn.1000-6621.2020.10.013
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.10.013
[1] | 杨越明, 孙小军, 许文芳. 辅助性T细胞17及调节性T细胞调节初治肺结核患者免疫功能的作用. 国际流行病学传染病学杂志, 2014,41(6):378-381. doi: 10.3760/cma.j.issn.1673-4149.2014.06.004. |
[2] | Kong B, Liu GB, Zhang JA, et al. Elevated serum IL-35 and increased expression of IL-35-p35 or-EBI3 in CD4+CD25+T cells in patients with active tuberculosis[J/OL]. Am J Transl Res,2016, 8(2):623-33.[2020-05-26]. Published online 2016 Feb 15. |
[3] |
Lee P, Leung CC. Year in review 2015: Lung cancer, pleural diseases, respiratory infections, bronchiectasis and tuberculosis, bronchoscopic intervention and imaging. Respirology, 2016,21(5):961-967. doi: 10.1111/resp.12779.
doi: 10.1111/resp.12779 URL pmid: 26998678 |
[4] | 中华人民共和国国家卫生和计划生育委员会.WS 288—2017 肺结核诊断. 2017-11-09. |
[5] | 中华医学会结核病学分会. 中国耐多药和利福平耐药结核病治疗专家共识(2019年版). 中华结核和呼吸杂志, 2019,42(10):733-749. doi: 10.3760/cma.j.issn.1001-0939.2019.10.006. |
[6] |
Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev, 2011,24(2):351-376. doi: 10.1128/CMR.00042-10.
doi: 10.1128/CMR.00042-10 URL pmid: 21482729 |
[7] |
Lyadova IV, Panteleev AV. Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers. Mediators Inflamm, 2015,2015:854507. doi: 10.1155/2015/854507.
doi: 10.1155/2015/854507 URL pmid: 26640327 |
[8] |
Morais-Papini TF. Systemic immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection. Immunobiology, 2017,222(11):1014-1024. doi: 10.1016/j.imbio.2017.05.016.
URL pmid: 28619539 |
[9] |
Fan L, Xiao H, Mai G, et al. Impaired M.tuberculosis Antigen-Specific IFN-γ Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary Tuberculosis. PLoS One, 2015,10(5):e0127087. doi: 10.1371/journal.pone.0127087.
doi: 10.1371/journal.pone.0127087 URL pmid: 26018190 |
[10] |
Adekambi T, Ibegbu CC, Cagle S, et al.Biomaskers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest, 2015,125(9):3723. doi: 10.1172/JCI83279.
doi: 10.1172/JCI84059 URL pmid: 26325037 |
[11] | 林俊锦, 王志刚, 许庆华. 老年肺结核患者淋巴细胞亚群及免疫球蛋白的变化及意义. 中国实用医药, 2013,8(13):51-52. |
[12] | 井楠, 刘海峰, 刘伟. 流式细胞术检测初治活动性肺结核患者血清T淋巴细胞亚群计数分析. 临床和实验医学杂志, 2018,17(7):774-777. doi: 10.3969/j.issn.1671-4695.2018.07.032. |
[13] |
Hussain T, Kulshreshtha KK, Yadav VS, et al. CD4+, CD8+, CD3+ cell counts and CD4+/CD8+ ratio among patients with mycobacterial diseases (leprosy, tuberculosis), HIV infections, and normal healthy adults: a comparative analysis of studies in different regions of India. J Immunoassay Immunochem, 2015,36(4), 420-443. doi: 10.1080/15321819.2014.978082.
doi: 10.1080/15321819.2014.978082 URL pmid: 25350657 |
[14] | 黄丽静, 陈焯彬, 韦永孜. 肺结核患者病情严重程度与免疫功能受损程度的相关性研究. 海南医学, 2016,27(9):1424-1426. doi: 10.3969/j.issn.1003-6350.2016.09.017. |
[15] | 沈洁, 吴妹英, 李苏梅. 初治和复治肺结核患者外周血淋巴细胞亚群的变化及其临床意义. 临床肺科杂志, 2019,24(2):208-212. doi: 10.3969/j.issn.1009-6663.2019.02.004. |
[16] |
Kamath A, Woodworth JS, Behar SM. Antigen-Specific CD8+T Cells and the Development of Central Memory during Mycobacterium tuberculosis Infection. J Immunol, 2006,177(9):6361-6369. doi: 10.4049/jimmunol.177.9.6361.
doi: 10.4049/jimmunol.177.9.6361 URL pmid: 17056567 |
[17] |
Guglielmetti L, Cazzadori A, Conti M, et al. Lymphocyte subpopulations in active tuberculosis association with disease severity and the QFT-GIT assay. Int J Tuberc Lung Dis, 2013,17(6):825-828. doi: 10.5588/ijtld.12.0361.
doi: 10.5588/ijtld.12.0361 URL pmid: 23676170 |
[18] |
Yang JD, Mott D, Sutiwisesak R, et al. Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages. PLoS Pathog, 2018,14(5):e1007060. doi: 10.1371/journal.ppat.1007060.
doi: 10.1371/journal.ppat.1007060 URL pmid: 29782535 |
[19] |
Ye W, Zhang SW, Peng WG, et al. Changes in lymphocyte subsets in the peripheral blood of patients with active pulmonary tuberculosis. J Int Med Res, 2009,37(6):1742-1749. doi: 10.1177/147323000903700610.
doi: 10.1177/147323000903700610 URL pmid: 20146872 |
[20] | 陆恩词, 朱颖蔚. 肺结核合并糖尿病患者T淋巴细胞亚群及红细胞免疫功能的变化及意义. 中国老年学杂志, 2017. 37(3):648-649. doi: 10.3969/j.issn.1005-9202.2017.03.055. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||